# Actelion Pharmaceuticals US Inc. – FDA Inspection, Oct 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/actelion-pharmaceuticals-us-inc/42933576-b78e-47aa-9776-8c1f99b939b9
Source feed: FDA_Inspections

> FDA inspection 1252745 of Actelion Pharmaceuticals US Inc., October 28, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252745
- Company Name: Actelion Pharmaceuticals US Inc.
- Inspection Date: 2024-10-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 4

## Related Officers

- [Company Rep](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)
- [Issuing Officer](https://www.keypedia.com/people/vanessa-e-coulter/add8407c-0df8-43ed-9f5a-8063880ce638)

Company: https://www.keypedia.com/companies/actelion-pharmaceuticals-us-inc/dcd7e330-a940-41bf-bf05-d121684e4612

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248